Emanuela Ferraro, MD

Medical Oncologist, Breast Cancer 🎗️ #bcsm clinical research fellow @MSKCancerCenter__ Cats lover🐾__southern soul 🇮🇹🌶️

[Carmine Valenza @ValenzaCarmine]

ESMO Breast 2027 in Milan

Official languages:
english +/- 🤌👌👍👋🤙

@myESMO

[G Curigliano MD PhD @curijoey]

Extending ET with OFS in premenopausal patients with node-positive eBC after 5 years of LHRHa treatment is associated with a clinically meaningful reduction in both invasive and distant breast cancer recurrences. https://t.co/BuV6VuJLf1 @IEOufficiale @LaStatale @myESMO @ASCO

[The Nobel Prize @NobelPrize]

Remembering the remarkable Marie Skłodowska Curie - awarded the 1903 physics prize and 1911 chemistry prize - who passed away #OTD in 1934.

[Antonio Marra @antoniomarraMD]

Grateful to @myESMO for the opportunity to share and promote our latest work.

In this recent paper (👉 https://t.co/C1a6Q3QuRY), we present a comprehensive overview of the current applications of AI applied to cancer pathology and explore how this field is rapidly evolving

[MSK Library @MSKLibrary]

Featured today by @MSKLibrary: Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System Disease

#ERBB2 #MetastaticBreastCancer #CNSMetastases #BreastCancerResearch #SurvivalOutcomes

@EmaFer_90 @Anne_S_Reiner @BouNassif_MD @UmbertoTosiMD @SamanthaBrown @DangTechNickel @MSKCancerCenter @Dr_N_Moss

https://t.co/YDrxWSplGp

[Emanuela Ferraro, MD @EmaFer_90]

This work is the result of an incredible collaboration between @MSK_DeptOfMed & @MSKNeurosurgery, working side by side every day to take care of pts with BrM. I'm truly honored to have been a part of this! Special thanks to @Dr_N_Moss for leading the project and to all co-authors

[Emanuela Ferraro, MD @EmaFer_90]

BrMs are the Achilles' heel of HER2+ breast cancer. We MUST do more and sharpen our focus on their patterns of presentation when designing clinical trials for this population. Our latest work shows that BrMs are not all the same. Check this out ⬇️🚀#bcsm @MSK_DeptOfMed @Dr_N_Moss

[JAMA Network Open @JAMANetworkOpen]

Patients with HER2+ metastatic breast cancer face a high risk of death due to CNS involvement, and those with CNS-only disease had longer overall survival. https://t.co/gGVfvppHNK @BouNassif_MD

[Nelson Moss @Dr_N_Moss]

CNS mets=increasingly the main challenge in HER2+ #breastcancer. Here we show that fully 55% of pts w/such spread suffer CNS-related mortality; even more so in the growing (+longer-surviving) population w/CNS-only disease
https://t.co/SwFbBZu6pZ

[Angelo Mangiante @angelomangiante]

Vola nei quarti #Sinner a Pechino. È il più forte.
È l'immagine più bella e PULITA dello sport italiano e mondiale.
È l'esempio di umiltà, sacrifici e serietà.
È il n.1 in campo e fuori.
Circondato da INVIDIA e NEFANDEZZE su di lui a tutti i livelli. Forza sempre Jannik ��

[Emanuela Ferraro, MD @EmaFer_90]

@qinglicya @RadOncUH Good luck!!! 💫🚀❣️

[Eleonora Nicolò @eleonora_nicolo]

Just out in EJC our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age
➡️Age, per se, should not represent a barrier when considering early-phase clinical trials as a treatment option
https://t.co/TiwSJfuTDV

[G Curigliano MD PhD @curijoey]

“A society grows great when older people plant trees whose shade they know they shall never sit in”

I truly believe that enhancing the careers of young oncologists is the best way to impact the lives of our patients and shape the future of global oncology #nextgenoncologists

[G Curigliano MD PhD @curijoey]

For 25 years, I've witnessed the profound impact of ESMO on nurturing the young generation of medical oncologists. Their unwavering support and inspiration are the pillars of our future in oncology. Let's continue to empower their bright minds 🌟 #FutureLeaders #MentorshipMatters

[Paolo Tarantino @PTarantinoMD]

There’s still time to vote for the ESMO Presidential elections! Full endorsement for @curijoey, a trailblazer in breast oncology, powerhouse of drug development, and terrific mentor for an entire generation of young oncologists.

Cast your vote here: https://t.co/aKgAmL5b0R

[Antonio Marra @antoniomarraMD]

🗳️@myESMO Presidency is open https://t.co/maRxp8UNO9
👉Endorse Giuseppe Curigliano's vision as ESMO President @curijoey

✅Devoted to foster the new generation of oncologists
✅Impact in Oncology through research, mentoring & education
✅Commitment for inclusivity and diversity

[Pier Paolo Berton Giachetti @PierPaoloBG]

No doubt! Vote for @curijoey @myESMO

[Flavia Jacobs @FlaviaJacobs_]

✔️we develop a #ML tool to predict #RSClin to refine DR risk and CT benefit for HR+HER2- #earlyBC
✔️our tool can accurately reproduce RSClin
✔️free web based link to access the tool ➡️ https://t.co/ORlPwYWnh5
✔️this tool may support treatment decision for HR+ eBC
#ESMOBreast24

[Emanuela Ferraro, MD @EmaFer_90]

Fresh off the press @JAMAOnc a strong international academic collaboration to show that less surgery is safe when chemotherapy works. Kudos to my dear friend @MontagnaGiacomo, @AndreaBarrio7 & team!!! @MSKCancerCenter #bcsm link below🎯

[Giacomo Montagna MD MPH @MontagnaGiacomo]

First post on my X Account -- thrilled to share our paper on the safety of axillary dissection omission after downstaging with NAC in node+ breast cancer patients --> today in @JAMAOnc🎗️https://t.co/Vd2CZ99CiF #bcsm @AndreaBarrio7 @MSKCancerCenter #OncoplasticBreastConsortium

[Onorina Laura Manzo @ManzoNory]

Solving the Riddle of the Sphingolipids in Coronary Artery Disease https://t.co/vWhf8sPsgp

Adding new insights to this fascinating unknown sphingolipids world. 🤔

[ESMO - Eur. Oncology @myESMO]

#WorldHealthDay: Health is a human right, and #CancerCare is a human priority. A recent report shows that #UniversalHealthcoverage in #oncology is still not a reality. 

To know more, read @darioT_’s article in the #ESMODailyReporter
👉https://t.co/p8Nq1LjStd

@WHO